Structure of the murine TRAF1 gene

Molecular Immunology

Volumn 36, Issue 9, 1999, Pages 611-617

  Dunn, Ian F ^a   Geha, Raif S ^a   Tsitsikov, Erdyni N ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Gene structure; Promoter sequences; TRAF1

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; IONOMYCIN; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY CD3; PHORBOL 13 ACETATE 12 MYRISTATE; RECEPTOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR I; UNCLASSIFIED DRUG;

ARTICLE; CYTOKINE PRODUCTION; DNA FLANKING REGION; EXON; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENE STRUCTURE; INTRON; MOLECULAR CLONING; NUCLEOTIDE REPEAT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RESTRICTION MAPPING; SEQUENCE ANALYSIS; SOUTHERN BLOTTING; TRANSCRIPTION INITIATION;

ANIMALS; B-LYMPHOCYTES; BASE SEQUENCE; CLONING, MOLECULAR; EXONS; GENE EXPRESSION; GENE EXPRESSION REGULATION; INTRONS; LYMPHOCYTE ACTIVATION; MICE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); PROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR; RESTRICTION MAPPING; T-LYMPHOCYTES; TISSUE DISTRIBUTION; TNF RECEPTOR-ASSOCIATED FACTOR 1; TRANSCRIPTION, GENETIC;

EID: 0032818286     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(99)00075-9     Document Type: Article

References (38)

1. Aizawa S., Nakano H., Ishida T., Horie R., Nagai M., Ito K., Yagita H., Okumura K., Inoue J., Watanabe T. Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NFkappaB activation. J. Biol. Chem. 272:1997;2042-2045.
2. Akiba H., Nakano H., Nishinaka S., Shindo M., Kobata T., Atsuta M., Morimoto C., Ware C.F., Malinin N.L., Wallach D., Yagita H., Okumura K. CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase. J. Biol. Chem. 273:1998;13353-13358.
3. Ansieau S., Scheffrahn I., Mosialos G., Brand H., Duyster J., Kaye K., Harada J., Dougall B., Hubinger G., Kieff E., Herrmann F., Leutz A., Gruss H.J. Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation. Proc. Natl Acad. Sci. USA. 93:1996;14053-14058. (retracted by Kieff E. In: Proc. Natl Acad. Sci. USA 1997 Nov 11; 94(23): 12732).
4. Arch R.H., Gedrich R.W., Thompson C.B. Tumor necrosis factor receptor-associated factors (TRAFs) - a family of adapter proteins that regulates life and death. Genes Dev. 12:1998;2821-2830.
5. Arch R.H., Thompson C.B. 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor kappaB. Mol. Cell Biol. 18:1998;558-565.
6. Baker S.J., Reddy E.P. Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene. 12:1996;1-9.
7. Boucher L.M., Marengere L.E., Lu Y., Thukral S., Mak T.W. Binding sites of cytoplasmic effectors TRAF1, 2, and 3 on CD30 and other members of the TNF receptor superfamily. Biochem. Biophys. Res. Commun. 233:1997;592-600.
8. Cao Z., Xiong J., Takeuchi M., Kurama T., Goeddel D.V. TRAF6 is a signal transducer for interleukin-1. Nature. 383:1996;443-446.
9. Cheng G., Cleary A.M., Ye Z.S., Hong D.I., Lederman S., Baltimore D. Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science. 267:1995;1494-1498.
10. Duckett C.S., Gedrich R.W., Gilfillan M.C., Thompson C.B. Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2. Mol. Cell Biol. 17:1997;1535-1542.
11. Durkop H., Foss H.D., Demel G., Klotzbach H., Hahn C., Stein H. Tumor necrosis factor receptor-associated factor 1 is overexpressed in reed-sternberg cells of Hodgkin's disease and Epstein-Barr virus-transformed lymphoid cells. Blood. 93:1999;617-623. (In Process Citation).
12. Gedrich R.W., Gilfillan M.C., Duckett C.S., Van Dongen J.L., Thompson C.B. CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins. J. Biol. Chem. 271:1996;12852-12858.
13. Horie R., Aizawa S., Nagai M., Ito K., Higashihara M., Ishida T., Inoue J., Watanabe T. A novel domain in the CD30 cytoplasmic tail mediates NFkappaB activation. Int. Immunol. 10:1998;203-210.
14. Hu H.M., O'Rourke K., Boguski M.S., Dixit V.M. A novel RING finger protein interacts with the cytoplasmic domain of CD40. J. Biol. Chem. 269:1994;30069-30072.
15. Ishida T., Mizushima S., Azuma S., Kobayashi N., Tojo T., Suzuki K., Aizawa S., Watanabe T., Mosialos G., Kieff E., Yamamoto T., Inoue J. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J. Biol. Chem. 271:1996;28745-28748.
16. Ishida T.K., Tojo T., Aoki T., Kobayashi N., Ohishi T., Watanabe T., Yamamoto T., Inoue J. TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling. Proc. Natl Acad. Sci. USA. 93:1996;9437-9442.
17. Jang I.K., Lee Z.H., Kim Y.J., Kim S.H., Kwon B.S. Human 4-1BB (CD137) signals are mediated by TRAF2 and activate nuclear factor-kappa B. Biochem. Biophys. Res. Commun. 242:1998;613-620.
18. Lee S.Y., Kandala G., Liou M.L., Liou H.C., Choi Y. CD30/TNF receptor-associated factor interaction: NF-kappa B activation and binding specificity. Proc. Natl Acad. Sci. USA. 93:1996;9699-9703.
19. Lee S.Y., Park C.G., Choi Y. T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors. J. Exp. Med. 183:1996;669-674.
20. Lee S.Y., Reichlin A., Santana A., Sokol K.A., Nussenzweig M.C., Choi Y. TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival. Immunity. 7:1997;703-713.
21. Liebowitz D. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients. N. Engl. J. Med. 338:1998;1413-1421. (see comments).
22. Mosialos G., Birkenbach M., Yalamanchili R., Vanarsdale T., Ware C., Kieff E. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell. 80:1995;389-399.
23. Mount S.M. A catalogue of splice junction sequences. Nucleic Acids Res. 10:1982;459-472.
24. Nakano H., Oshima H., Chung W., Williams-Abbott L., Ware C.F., Yagita H., Okumura K. TRAF5, an activator of NF-kappaB and putative signal transducer for the lymphotoxin-beta receptor. J. Biol. Chem. 271:1996;14661-14664.
25. Natoli G., Costanzo A., Ianni A., Templeton D.J., Woodgett J.R., Balsano C., Levrero M. Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science. 275:1997;200-203.
26. Pullen S.S., Miller H.G., Everdeen D.S., Dang T.T.A., Crute J.J., Kehry M.R. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization. Biochemistry. 37:1998;11836-11845.
27. Regnier C.H., Tomasetto C., Moog-Lutz C., Chenard M.P., Wendling C., Basset P., Rio M.C. Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma. J. Biol. Chem. 270:1995;25715-25721.
28. Rothe M., Sarma V., Dixit V.M., Goeddel D.V. TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40. Science. 269:1995;1424-1427.
29. Rothe M., Wong S.C., Henzel W.J., Goeddel D.V. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell. 78:1994;681-692.
30. Sato T., Irie S., Reed J.C. A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40. FEBS Lett. 358:1995;113-118.
31. Siemienski K., Peters N., Scheurich P., Wajant H. Organization of the human tumour necrosis factor receptor-associated factor 1 (TRAF1) gene and mapping to chromosome 9q33-34. Gene. 195:1997;35-39.
32. Speiser D.E., Lee S.Y., Wong B., Arron J., Santana A., Kong Y.Y., Ohashi P.S., Choi Y. A regulatory role for TRAF1 in antigen-induced apoptosis of T cells. J. Exp. Med. 185:1997;1777-1783.
33. Tsitsikov E.N., Wright D.A., Geha R.S. CD30 induction of human immunodeficiency virus gene transcription is mediated by TRAF2. Proc. Natl Acad. Sci. USA. 94:1997;1390-1395.
34. Wang C.Y., Mayo M.W., Korneluk R.G., Goeddel D.V., Baldwin A.S. Jr. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science. 281:1998;1680-1683.
35. Wong B.R., Josien R., Lee S.Y., Vologodskaia M., Steinman R.M., Choi Y. The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor. J. Biol. Chem. 273:1998;28355-28359.
36. Xu Y., Cheng G., Baltimore D. Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses. Immunity. 5:1996;407-415.
37. Yamamoto H., Kishimoto T., Minamoto S. NF-kappaB activation in CD27 signaling: involvement of TNF receptor-associated factors in its signaling and identification of functional region of CD27. J. Immunol. 161:1998;4753-4759.
38. Yeh W.C., Shahinian A., Speiser D., Kraunus J., Billia F., Wakeham A., de la Pompa J.L., Ferrick D., Hum B., Iscove N., Ohashi P., Rothe M., Goeddel D.V., Mak T.W. Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity. 7:1997;715-725.